Natalia Lysenko

Troika Capital Partners (TCP) is the private equity subsidiary of Sherbank Corporate & Investment Banking ZAO, itself a subsidiary of State-owned Central Bank of the Russian Federation. Established in 2006, the firm manages both private equity and venture capital funds. They are based in Moscow and are the investment advisor to the Russia New Growth fund, launched by Troika Dialog and Temasek Holdings (Singapore). TCP has multiple offices in major Russian cities in addition to subsidiaries in New York, London, Kiev and Cyprus.

Leader CJSC /Private Equity/ (Leader CJSC PE) is the venture capital subsidiary of Leader CJSC founded in 1993. The firm headquartered in Moscow, Russia.

Maxfield Capital Management LLC (Maxfield Capital) is a venture capital firm founded in 2013 by Alexander Turkot and Alexander Lazarev. The firm is headquartered in New York with additional offices in San Francisco, London, Moscow and Tel Aviv.

DrChrono, Inc. provides medical platform for physicians and patients. It offers HER, practice management, revenue cycle management, patient portal, mobile HER, pricing, features, and e-Prescribing. The firm also offers cloud based scheduling, clinical documentation, patient portal, and billing software. The company was founded by Daniel Kivatinos and Michael Nusimow in August 2009 and is headquartered in Mountain View, CA.

PressReader, Inc. distributes multi-channel newspaper and magazine content. The firm distributes magazine and Newspapers to market, sell and/or print publications worldwide and it has online at PressDisplay.com for onscreen viewing and listening. It instantly translates articles into different languages, listen to publications on PCs, Macs or mobile devices. The company was founded by Alexander Kroogman, Miljenko Horvat, Anatoly Karachinsky and Esther Dyson in 1999 and is headquartered in Richmond, Canada.

Intel Capital Corp (Intel Capital) is a venture capital subsidiary of Intel Corp founded in 1991 by Les Vadasz, and Avram Miller. The firm is headquartered in Wilmington, Delaware.

HemaCore LLC operates as a biotech company that develops medical devices and methods for hematology. Its product Thrombodynamics is a new global assay for monitoring and prognosis of blood coagulation disorders: bleeding and thrombosis, precursors of heart attacks and strokes. The company was founded in April 2010 by Igor Pivovarov and is headquartered in Moscow, Russia.